Antara compliance-enhancing features


For the treatment of primary hypercholesterolemia, mixed dyslipidemia, and severe hypertriglyceridemia as adjunctive therapy to diet

Give your patients efficacy with compliance-enhancing features

  • Small, once-daily capsule makes it easy for patients to take with or without food1,2
  • Refill Program improves patient compliance*3
    Participants stayed on ANTARA® 3 times longer and obtained 1.5 more refills
  • $0 Co-pay card makes it affordable for eligible patients to stay on regimen
  • Pharmacy and Managed Care Support programs for your office staff to help manage coverage needs

*Compared to those on a generic without a program.

Refill data was collected by Trial Card over the course of one year.

Offer void where prohibited. Offer only valid for eligible commercially insured patients. In some instances patients may pay more than $0. For example: deductibles.

Always state DAW to ensure patients receive Antara

To ensure your patient gets ANTARA®, always state DAW

  1. Davidson MH, Bays H, Rhyne J, et al. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2005;27(6):715-727.
  2. ANTARA® Prescribing Information.
  3. Data on file. Lupin Pharmaceuticals, Inc.